Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-8-2
pubmed:databankReference
pubmed:abstractText
Guidelines for the treatment of patients with allergic rhinitis (AR) recommend intranasal corticosteroids as first-line therapy. In clinical trials, however, only 50% of patients obtain excellent symptom control.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1081-1206
pubmed:author
pubmed:copyrightInfo
Copyright 2010 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Print
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
155-61
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
pubmed:affiliation
Section of Otolaryngology-Head and Neck Surgery, The University of Chicago Medical Center and Pritzker School of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't